VEGFA and cancer: If clinical trials of anti-VEGF monotherapy have generally had negative results in patients with solid tumors, combination approaches of anti-VEGF therapy with conventional chemotherapy have demonstrated improved survival in cancer patients compared with chemotherapy alone.